New: NCI-funded clinical trial search
Mednet Logo

When treating resected brain metastases with post-op SRS, what dose, fractionation and PTV margin do you use for large (>3 cm) cavities?

This question is part of our ASTRO 2026 collaboration, inspired by the Plenary Session Presentation "Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis" by Dr. Paul Brown, MD
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Fox Chase Cancer Center
Answered on

I would refer you to Scott Soltys' work:

Choi et al., PMID 22652105

Soltys et al., PMID 17881139

This is also useful:

Brennan et al., PMID 24331659

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Mayo Clinic Florida
Answered on

I think it's a reasonable approach (fractionation). It is certainly one we use at our institution. Having said that, this is only based on retrospective reports. It will be interesting to see the manuscripts of the MDACC and Alliance trials as the reported local control rates were lower than expecte...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Harvard Medical School
Answered on

In fact, I rarely use true postoperative SRS. A lower fractional dose enables using larger CTV margins safely if there is concern for potential residual microscopic disease and risk for leptomeningeal disease (LMD). CTV margin also depends on how linear the surgical bed surface is. The entirety of t...

Join for free or sign in to see the full answer